Skip to main content
Fig. 3 | Gut Pathogens

Fig. 3

From: Salivary shield: Rhodnius prolixus salivary glandular extract reduces intestinal immunopathology and protects against Toxoplasma gondii infection

Fig. 3

Systemic cytokines were analyzed using CBA and ELISA in C57BL/6 mice, whether infected or not with T. gondii, and treated or not with SGE (30 µg) during chronic or acute infection phases. The cytokines were measured in mice serum, and data are expressed as the mean and standard deviation of cytokine secretion (pg/mL). A TNF, B IFN-γ, C MIF, D IL-4, E IL-10, F IL-2, G TGF-β, H IL-17, and (I) IL-6. # Represents significant differences between treated and untreated groups in the same experimental condition (treated and untreated mice). *Represents differences between different experimental conditions (uninfected, acute infection, and chronic infection). Tests were performed using 2-way ANOVA followed by Tukey’s multiple comparison post-test, and differences were considered significant when * = 0.05, ** = 0.01, *** = 0.001. # = 0.05, ## = 0.01, ### = 0.001 (n = 10 mice per group). IFN-γ, TNF, IL-17, IL-6, IL-4, IL-2, and IL-10 were measured by CBA, and MIF and TFG-β were measured by ELISA

Back to article page